Dr. Barry W. Brown is the Director of the Cancer Information Systems Resource (CISR), which is housed in the Department of Biomathematics and is located in the Houston Main Building. This resource provides scientific computational capabilities to meet the diverse needs of peer-reviewed and funded M.D. Anderson researchers. Those needs are identified through collaborations with these investigators. Members of the CISR are well qualified to provide computer code meeting these needs because they are familiar with numeric and computational methods, sources of quality computer code, and general quantitative and statistical methodology and because they understand standards for good code. The primary computational servers for this Resource are two fast DEC Alpha machines running Unix. Each member of the Resource accesses these machines via a dedicated PC or Macintosh computer. The software used by the Resource includes a variety of statistical systems, symbolic and numeric mathematical systems, and programming aids. The resource's software is widely used not only by CISR members but also by the Biostatistical Resource Group (BRG), clinical and basic-science investigators at M.D. Anderson, and cancer and other biomedical researchers. The software the CISR develops is posted on the World Wide Web and submitted to many archives from which it is freely available. The CISR has been continuously funded from the Cancer Center Support Grant (CCSG) since 1975, when M.D. Anderson when received its first CCSG, and continues to provide invaluable (and otherwise unavailable) services to investigators with peer-reviewed grants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016672-26
Application #
6481850
Study Section
Project Start
2001-08-01
Project End
2002-06-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
$254,104
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Dutcher, Giselle M A; Bilen, Mehmet Asim (2018) Therapeutic Vaccines for Genitourinary Malignancies. Vaccines (Basel) 6:
Kurnit, Katherine C; Dumbrava, Ecaterina E Ileana; Litzenburger, Beate et al. (2018) Precision Oncology Decision Support: Current Approaches and Strategies for the Future. Clin Cancer Res 24:2719-2731
Duplisea, Jonathan J; Mokkapati, Sharada; Plote, Devin et al. (2018) The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World J Urol :
Jordan, V Craig (2018) Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive. Clin Cancer Res 24:3480-3482
Pantano, Naitielle; Hunt, Brady; Schwarz, Richard A et al. (2018) Is Proflavine Exposure Associated with Disease Progression in Women with Cervical Dysplasia? A Brief Report. Photochem Photobiol 94:1308-1313
Mehrvarz Sarshekeh, Amir; Xiong, Henry Q; Iizuka, Kenzo et al. (2018) Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer. Invest New Drugs 36:895-902
Lang, Frederick F; Conrad, Charles; Gomez-Manzano, Candelaria et al. (2018) Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol 36:1419-1427
Ishizawa, Jo; Nakamaru, Kenji; Seki, Takahiko et al. (2018) Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition. Cancer Res 78:2721-2731
Talluri, Rajesh; Shete, Sanjay (2018) An approach to estimate bidirectional mediation effects with application to body mass index and fasting glucose. Ann Hum Genet 82:396-406
Bhadra, Anindya; Rao, Arvind; Baladandayuthapani, Veerabhadran (2018) Inferring network structure in non-normal and mixed discrete-continuous genomic data. Biometrics 74:185-195

Showing the most recent 10 out of 12418 publications